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A co-culture nanofibre scaffold 
model of neural cell degeneration in 
relevance to Parkinson’s disease
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Current therapeutic strategies for Parkinson’s disease (PD) aim to delay progression or replace damaged 
neurons by restoring the original neuronal structures. The poor regenerative capacity of neural tissue 
highlights the need for the development of cellular environments to model the pathogenesis of PD. In 
the current work, we have characterised the growth, survival and response to PD mimetics of human 
SH-SY5Y neuroblastoma and U-87MG glioblastoma cell lines cultured on polyacrylonitrile (PAN) and 
Jeffamine® doped polyacrylonitrile (PJ) nano-scaffolds. Differentiation induced by a range of agents 
was evaluated by immunoassays of neural protein biomarkers. PAN and PJ nanofibre scaffolds provided 
suitable three-dimensional (3D) environment to support the growth, differentiation and network 
formation of dopaminergic neuron- and astrocyte-like cell populations, respectively. The scaffolds 
selectively supported the survival and differentiation of both cell populations with prolonged neuronal 
survival when exposed to PD mimetics in the presence of astrocytes in a co-culture model. Such 3D 
nanoscaffold-based assays could aid our understanding of the molecular basis of PD mimetic-induced 
Parkinsonism and the discovery of neuroprotective agents.
Parkinson’s disease (PD), a progressive neurodegenerative disorder, is caused by loss of dopaminergic neurons 
in the substantia nigra of the midbrain and affects 1–2% of the population over 65 years of age1. Cells of the 
substantia nigra produce the neurotransmitter dopamine to control and coordinate motor functions. Their loss 
results in Parkinsonism, which manifests itself as muscle rigidity, tremors, slowness and difficulty in controlling 
movement2. Despite the prevalence of PD and the substantial efforts in studying disease pathogenesis, very 
limited disease-modifying agents exist. Current strategies only delay disease progression while novel proposed 
approaches attempt to reverse dopaminergic neuronal loss by implantation of human embryonic stem cells to 
restore neuronal architecture and promote neurite regeneration3,4. The development of new treatments is ham-
pered by the scarcity of suitable in vitro models to screen potential drug candidates.
Neuron and astrocyte based cell models have been used to study neurodegenerative disease and CNS injuries. 
Neurons are carriers of electrochemical signals to the striatum that facilitates movement and these dopaminergic 
neurons are supported by the lowest number of astrocytes for any brain region, and hence vulnerable5. In fact, 
astrocytes are critical in the modulation of the neurotoxic effects of many inhibitors that induce experimental 
Parkinsonism and can invoke a neurotoxic to neurotrophic response. Indeed, astrocytes harbour an effective neu-
roprotective arsenal that includes neurotrophic factors and anti-oxidative stress molecules6,7. An intimate rela-
tionship exists between neurons and glia following response to injury. For example, during conditions of oxidative 
stress, neurons can utilise secreted astrocyte derived antioxidant molecules to reduce internal oxidative stress8,9.
Electrospun nanofibres scaffolds for 3D tissue engineering emerged during the 1990s10,11. 3D in vitro tissue 
models hold considerable value for a breadth of studies, from a basic understanding of neuronal-glial develop-
ment through to the design of improved screening platforms for potential neuroprotective agents. Traditionally, 
in vitro neuronal cell culture has been performed using two-dimensional (2D) monolayer cultures on cell 
adherent tissue culture plastic (TCP) and have been criticised for not providing a native cellular environment, 
resulting in remodelling of cellular architecture and changes in gene expression12,13. The advantages of using 
3D nanofibre scaffolds to mimic the in vivo environment are: (1) enhanced cellular architecture and physiol-
ogy14, (2) greater cell to cell contact and interaction, with increased intercellular signalling15, (3) enhanced cell 
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differentiation for complex tissue development15, (4) greater surface area and porosity with enhanced cell adhe-
sion and improved access to metabolites and nutrients16. Cell behaviour is influenced by surface physicochemi-
cal properties including nanotopography, surface charge and protein adsorption/immobilisation17 and therefore 
nanofibres can be manipulated by copolymerization or by polymer blending of various synthetic and/or natural, 
non-biodegradable/biodegradable materials18,19.
In this study, novel electrospun 3D nanofibre scaffolds have been developed to improve discovery of neuropro-
tective agents for PD. The approach used electrospun PAN, a pure carbon based polymer and Jeffamine® infused 
PAN. Jeffamine is a highly versatile polymer containing primary amino groups attached to the end of a polyether 
backbone generally based on propylene oxide (PO), ethylene oxide (EO) or a mixture of both (Huntsman, UK). 
Jeffamine polymer is commonly used as a copolymer to alter chemical and physical properties of other polymers.
SH-SY5Y human neuroblastoma and U-87MG human glioblastoma cell lines have been used to investigate 
several disorders including Parkinson’s disease, neurogenesis and other brain cell characteristics. Several studies 
have shown SH-SY5Y cells are capable of differentiating into mature dopaminergic neurons20,21 whereas U-87MG 
cells can be induced to differentiate into astrocytes22. Here, we have demonstrated that the chosen scaffolds are 
capable of harbouring these cell lines and support long-term cell survival, proliferation and differentiation using 
multiple differentiating agents. Cellularised nanoscaffolds were exposed to inhibitor treatments mimicking PD 
pathophysiology. Results confirmed that PAN nanoscaffolds prolonged the survival of SH-SY5Y cell cultures and 
PJ for U-87MG cultures, and that the 3D cultures have better proliferation and survival than 2D cultures.
Results
Rheometer measurement. The extensional viscosity of both PAN and PJ electrospinning formulations 
were measured using the HAAKE- CaBER™ Rheometer. The results are important as part of an in process mon-
itoring check on the molecular weight distribution of the PAN polymer used to make the batch. Higher average 
molecular weight electrospinning formulations have higher viscosity than lower. Subsequently, higher viscos-
ity formulations produce nanofibres with larger diameters than lower for the same electrospinning set up and 
process parameters as well as the potential for incomplete desolvation of the nanofibre during synthesis which 
results in solvent welds where one nanofibre touches another. Hence varying viscosities between batches affects 
the cellular micro-environment and cell response. For an in vitro model it is important to produce consistent 3D 
nanofibre scaffolds from one batch to another. For PAN the shear viscosity was 0.7102 Pa.s with a breakup time 
of 0.298 seconds (Fig. 1I) and shear viscosity of 0.7030 Pa.s with breakup time of 0.218 seconds for PJ (Fig. 1J).
Electrospun PAN and PJ nanofibres. Using the Phenom SEM FiberMetric software, 100 different meas-
urements were analysed for each sample. The data is represented in an even mean distribution among the one 
hundred measurements with standard error and standard error mean (±). The average fibre diameters for PAN 
and PJ were 524 ± 108 nm and 520 ± 110 nm, respectively (Fig. 1B,F). Measurements from optical coherence 
tomography (OCT) data determined the average thickness of the scaffolds to be 30 µm for PAN and 33.5 µm 
for PJ (Fig. 1D,H). Contact angle values were 112.7° for PAN and 36.1° for PJ. Hence the PAN nanoscaffolds are 
hydrophobic and PJ hydrophilic (Fig. 1C,G).
Culture of neural cells on nanoscaffolds. Coomassie stained cultures visualised using a light microscope 
(Nikon Eclipse TS100) showed that neural cells could be cultured successfully on PAN and PJ fibres. Morphology 
of cells was also observed using SEM. Results confirmed that the cells were able to attach to both types of polymer 
(Fig. 2A,B,D and E). Indeed, SEM images showed both cell types were able to grow within the fibres, adapting to 
the 3D structure (Fig. 2C,F).
Growth and proliferation of neural cells on nanofibres. The results show that SH-SY5Y cells were able 
to proliferate and survive longer on PAN fibres (Fig. 3A) compared to PJ fibres (Fig. 3B), while the rate of prolif-
eration was reduced on fibres in comparison to culture plastic. In contrast, U-87 MG cells were able to proliferate 
and survive longer on PJ (Fig. 3D) (Fig fibres compared to PAN fibres (Fig. 3C). Similarly, the rate of proliferation 
was reduced on the PJ fibres compared to tissue culture plastic (TCP). It was noticed that cells grown on TCP 
entered log phase from day 3 and remained in the stationary phase for day 5 and 7, and subsequently began to die 
from day 9. Similar profiles were observed for SH-SY5Y cells cultured on PJ andU-87MG on PAN. SH-SY5Y on 
PAN and U-87MG on PJ (Fig. 3A,D) showed a steady increase and continued to proliferate within the log phase 
for 11 days.
Differentiation of SH-SY5Y and U-87MG. Cells were induced to differentiate using three different 
agents known to induce neural differentiation. Immunofluorescence images obtained from differentiating cells 
showed that neuronal SH-SY5Y cells were able to extend neurites on PAN fibres and that these cellular pro-
cesses were stained positive for βIII tubulin, a mature neuronal marker. Both retinoic acid (RA) (Fig. 4B,E) and 
B27 (Fig. 4C,F) supplement showed similar results with extended βIII tubulin positive neurites compared to the 
non-treated control (Fig. 4A,D). However, on PJ fibres SH-SY5Y cells struggled to grow and differentiate. In 
contrast, U-87MG cells cultured on PJ showed improved cell growth and differentiation as highlighted by GFAP 
positive staining of cel-lular extensions showing induced astrocyte differentiation. U-87MG cells struggled to 
grow and differentiate in PAN fibres. GFAP was observed in U-87MG exposed to both dbcAMP (Fig. 4H,K) and 
B27 supplement (Fig. 4I,L) compared to the undifferentiated control (Fig. 4G,J).
Expression levels of differentiation markers. Levels of multiple differentiation markers were examined 
using western blotting. Phosphorylated neurofilament heavy chain (axon and neuronal maturity marker), βIII 
tubulin (mature neuronal marker) and synaptophysin (synaptic and neuronal network maturity marker) were 
measured for SH-SY5Y cells and GFAP expression for U-87MG cells. To identify the markers of differentiation, 
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both cell types were induced to differentiate on nanofibres and plates for seven days. Cell lysates were prepared, 
and the expression levels of the different proteins were compared. Our results indicate that expression of phos-
phorylated neurofilament-H (200 kDa), βIII tubulin (50 kDa) and synaptophysin (34 kDa) increased when cells 
Figure 1. Characterisation of PAN and PJ scaffolds. Panels A–D and E–H represent PAN and PJ nanofibre 
scaffolds respectively. (A,E) show SEM analysis. (B,F) shows fibre diameter data. (C,G) shows contact angle 
measurement. (D,H) shows OCT image analysis for thickness. Graph (I) shows strain diameter vs time of PAN 
and PJ electrospinning formulation. Graph (J) shows the strain diameter vs the strain rate. Considering the two 
variables. PAN and PJ, the  rheology data was analysed using unpaired t-test with Welch’s correction and show 
normal distributions with equal variance. The Welch’s t-test was used for unequal variances, but the assumption 
of normality was maintained.
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were differentiated on PAN fibre compared to cells cultured on TCP (Fig. 5A–C). Poor expression of these pro-
teins was observed from cells differentiated on PJ fibres. U-87MG cell extracts exhibited high expression of GFAP 
(50 kDa) on PJ fibre compared to TCP while low expression of GFAP was observed in undifferentiated (control) 
and B27 supplementation on PJ fibre (Fig. 5D). Both cell types expressed higher levels of neural marker protein 
when differentiated with B27 supplementation compared to RA and dbcAMP.
Effects of PD mimetics on undifferentiated SH-SY5Y and U-87 MG cells. Different treatments 
capable of mimicking PD paradigms (namely mitochondrial impairment, glutathione depletion and proteasome 
inhibition) were incubated with SH-SY5Y and U-87MG cultured on PAN and PJ, respectively for 72 hours. The 
effect of the treatments on cells cultured on both nanofibres and plate were examined by analysing cell viability 
using both MTT reduction and CellTiter-Glo 3D® assays (Fig. 6). The PD mimetic treatments used in this study 
were rotenone and MPTP to induce complex 1 inhibition, MG132 inducing proteasome inhibition and BSO, a 
glutamylcysteine synthetase inhibitor, to reduce glutathione levels. The results indicated that the cells exposed 
to treatments on nanofibres were more sensitive to the toxins compared to those grown on TCP, as they showed 
increased susceptibility to cell death.
Effects of PD mimetics in a co-culture model with differentiated cells. To investigate the ability 
of glial cells to support neuronal cells, toxicity tests were performed using a co-culture model of mature neurons 
from SH-SY5Ycells and astrocytes differentiated from U-87 MG cells (as explained in Section 4.10). Both cell 
types were differentiated using the B27 supplement and exposed to low levels of PD mimicking inhibitors. Our 
results showed that neurons on PAN fibres have prolonged survival in the presence of inhibitors when cultured as 
a co-culture along with astrocytes (Fig. 7A). Similar effects were also observed in astrocytes cultured on PJ fibres 
(Fig. 7B). Both cell types showed prolonged steady survival for nine days and very gradual cell death after day 11. 
When monocultures of differentiated SH SY5Y and U-87MG on nanofibre scaffolds were exposed to inhibitors 
for 72 hours, both cell types showed a heightened sensitivity to the different inhibitors but also exhibited a less cell 
death compared to TCP (Fig. 7C,D). In Fig. 7A,B show that both cells grown in co-culture together can grow for 
a period of 20 days (control). However, in the presence of inhibitors viability was compromised from day 11 for 
both cell types. In comparison, when cells were grown in a single culture (Fig. 7C,D) cell viability was compro-
mised from early as day 3. Further exposure resulted in complete loss of viability, and therefore data beyond day 
3 for this single culture experiment is not shown.
Figure 2. Neural cell attachment to scaffolds examined by Coomassie blue staining and SEM. Panels (A–C) 
show SH-SY5Y cells and (D–F) are U-87 MG cells. (A,D) Show light microscope image of Coomassie-stained 
cells on TCP and (B,E) on fibres. Panels (C,F) show SEM images of SH-SY5Y and U-87 MG cells on PAN and 
PJ, respectively. Cells were seeded at a density of 5 × 104 cells/well for both TCP and fibre. (A,B,D,E) Scale bar 
represents 100 µm.
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Discussion
Nanofibre scaffolds have the ability to support and provide a suitable habitat for cells to attach, proliferate and 
differentiate23. Non-degradable, synthetic PAN nanofibres scaffolds were used in this study because their mechan-
ical properties enable robust cell cultures to be produced. Jeffamine® ED-2003, a polyetheramine was mixed with 
PAN and N,N-dimethylformamide (DMF), then electrospun to produce PJ nanofibres. Rheometer measurements 
clearly showed that both PAN and PJ formulations have similar extensional viscosity and very similar strain 
breakup time. (Fig. 1I,J). Conditions were optimised in respect of polymer preparation, temperature, humidity, 
flow rate and the voltage to produce fibres with mean diameters between 500–600 nm, pore size of ~4000 nm2 and 
the scaffolds thicknesses of 30 µm and 33.5 µm for PAN and PJ, respectively (Fig. 1). The contact angle measure-
ment using water drop test confirmed PAN scaffolds are hydrophobic24 and addition of 5% Jeffamine® changed the 
physical property of the fibres to hydrophilic (Fig. 1C,G). All scaffolds were sterilised using a 30-minute wash in 
70% ethanol, with < 1% increase in the fibre diameter observed for both and this method showed no other major 
changes in the physical or chemical structure of the nanofibres. (Shown in supplementary data Figs. 1 and 2).
SH-SY5Y human neuroblastoma and U-87MG human glioblastoma cells were used to investigate the ability 
of the synthetic nanofibre scaffolds to facilitate cell adhesion, proliferation & differentiation. The results show that 
PAN and PJ nanofibres are suitable biomaterials to produce random nanofibre scaffolds that support neuronal 
and glial cells, respectively. The biomaterial preference for each cell type was evident in each cell type’s ability 
to attach and grow over a period of 11 days on nanofibre scaffolds. In both cases, cell growth and survival were 
maintained for longer on nanofibre scaffolds compared to conventional TCP. Several studies have reported the 
benefits and enhancement of cell metabolism when cultured on the 3D nanofibrillar surface25,26. The preferential 
attachment and growth of glial cells to PJ rather than PAN highlight potential differences in the ECM, which 
promotes the adhesion and proliferation of cells27,28. The composition of nanomaterials influences cell growth & 
survival due to topographic and biochemical cues induced by their unique physical and chemical properties29. 
Figure 3. Analysis of MTT reduction by neural cell lines grown on fibres and TCP. MTT reduction assays were 
performed to compare cell growth and metabolic activity on fibres and TCP for 11 days. Shown are SH-SY5Y 
(A,B) and U-87 MG cells (C,D) cultured on PAN (A,C) and PJ fibres (B,D). SH-SY5Y and U-87MG cells grown 
on PAN and PJ fibres, respectively showed a gradual increase in MTT reduction, whereas SH-SY5Y on PJ and 
U-87MG on PAN showed a gradual fall in metabolic activity. Cells were seeded at a density of 5 × 104 cells/well 
for both TCP and fibre. Values were converted to percentage of control (day 1) and are expressed as the % MTT 
reduction ± SEM where n = 6*, Statistical comparison was performed for plate vs fibres using the Two-Way 
ANOVA with Sidak’s multiple comparisons tests where *p < 0.05, **p < 0.01, ***p < 0.001.
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When growing co-cultures, it is potentially more desirable to culture cells onto 3D scaffolds that are capable of 
mimicking the native ECM. The improved growth and survival of both cells types could also be attributed to the 
physical properties of the nanofibres and fully suspended, highly porous, 3D nanofibres structures allows cells 
greater access to nutrients as well as toxins compared to cells cultured on 2D TCP30,31.
Comparative information about neuronal and glial cells cultured on PAN and PJ fibres was not previously 
available in the literature. Our data confirm that both glial and neuronal cells are capable of attaching to and 
proliferating on PAN and PJ fibres, showing the ability to differentiate on specific nanofibres. SH-SY5Y cells had 
a preference for PAN fibres whereas U-87MG cells had a preference for PJ. It may be that hydrophobic surfaces in 
PAN scaffolds facilitate cell:cell interactions in neuronal cultures in a manner that favours neuronal differentia-
tion, while a more hydrophilic scaffold favours glial cell attachment and differentiation. Further work will help to 
establish the molecular basis of these phenomena. Prolonged survival and proliferation of neuronal and glial cells 
on both PAN and PJ was investigated by allowing the cells to grow on these materials for 11 days. The cell viability 
Figure 4. Immunofluorescence analysis of neural cell differentiation. SH-SY5Y (A–F) and U-87MG (G–L) 
cells were induced to differentiate on both PAN and PJ fibres respectively. SH-SY5Y cells were induced to 
differentiate with RA and B27 supplement. U-87MG were induced to differentiate with dbcAMP and B27 
supplement. Red represents βIII tubulin (Panels A–F) and GFAP (Panels G–L), Blue represents DAPI nuclei 
stain, and green represents autofluoresence from nanofibres. Cells were seeded at a density of 5 × 104 cells/well 
for both TCP and fibre. Scale bar represents 100 µm.
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data (Fig. 3) obtained from both fibres types and plate showed that the cells were able to survive longer on fibres 
than on TCP. This may be due to the increased cell membrane surface area available to access nutrients and gases 
from the medium. SH-SY5Y cells showed prolonged survival on PAN and U-87MG on PJ fibres, respectively. The 
ability of these cells to adapt to specific surfaces opens up a range of possibilities such as targeted cell growth and 
cell channelling.
SH-SY5Y cells were induced to differentiate into matured neurons showing extended axonal growth and 
expressing high levels of the neuronal marker βIII tubulin, whereas U-87 MG cell were induced to differentiate 
to astrocytes expressing high levels of the astrocyte-specific intermediate filament protein GFAP. Both cell types 
Figure 5. Expression of differentiation protein markers on Western blots. Marker protein levels were 
determined in lysates of SH-SY5Y (A–C) and U-87MG (D) cells cultured on both PAN and PJ fibres determined 
by western blot and densitometry analysis. β-actin at 42 kDa was used as loading control for NF-H and 
vinculin at 120 kDa for βIII tubulin, synaptophysin and GFAP. Densitometry values obtained were normalised 
against loading control. Results are expressed at the mean percentage ± SEM (n = 3). Asterisk (*) indicates 
changes on fibres that are significantly different (*p < 0.05, **p < 0.01 or ***p < 0.001) compared to TCP for 
undifferentiated (control) and the differentating agents were determined by Two-Way ANOVA with Sidak’s 
multiple comparisons tests.
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were exposed to multiple differentiation-inducing agents including RA for SH-SY5Y and dbcAMP for U-87MG 
cells32–34. The B27 supplement is a commercially available product that is commonly used for the survival of pri-
mary neurons and neural cell differentiation35,36 and was used in this study as an alternative differentiating agent. 
Several components in the B27 supplement have shown the ability to support healthy neuron growth including 
neurite development, synapse formation and neurotransmitter release in primary cells37. We examined whether 
B27 could promote axonal generation in SH-SY5Y cells and to differentiate U-87MG cells into astrocytes express-
ing high levels of GFAP. Our results showed that both cell lines were capable of differentiating on their preferred 
fibre scaffolds. As determined by indirect immunofluorescence, SH-SY5Y cells showed high expression of the 
neuronal markers βIII tubulin, phosphorylated neurofilament heavy chain on PAN fibres and U-87MG cells 
expressed higher levels of the astrocyte specific intermediate filament protein GFAP and exhibited star-shaped 
astrocytic morphology on PJ (Fig. 4). The increased levels of expression of these proteins and the neuronal marker 
synaptophysin were also confirmed in their respective cell types using Western blot analysis38–40. All protein bio-
markers showed increased levels when cells were induced to differentiate on their preferred nanofibre scaffold. 
Furthermore, these levels were elevated in response to either dbcAMP or B27 supplementation (Fig. 5D).
While neuronal degeneration is a major event in PD, astrocytes are known to play a major role both in neuro-
protection and the inflammatory response in PD41–43. Therefore, after identifying the ability of both cell types to 
survive and differentiate with respect to fibre type, it was important to determine the response of both SH-SY5Y 
and U-87MG cells when exposed to PD mimetics compared to cells grown on TCP (Fig. 6). Complex1 impair-
ment, proteasome inhibition, and glutamylcysteine synthetase inhibition leading to neuronal degeneration are 
common pathophysiological responses observed and studied in PD44–47. Rotenone and MPTP are commonly 
used to induce complex 1 inhibition48,49, MG 132 mimics proteasome inhibition50 and BSO promotes glutam-
ylcysteine synthetase inhibition47. We used rotenone, MPTP, MG132 and BSO to create PD-like conditions in 
SH-SY5Y and U-87MG cells cultured on both TCP and PAN/PJ fibres. Our results showed that the cells on fibres 
exhibited higher sensitivities to the different PD mimetics compared to cells grown on conventional TCP. This 
Figure 6. Effect of PD mimetics on mitotic SH-SY5Y and U-87MG cells. SH-SY5Y (A,C) and U-87MG (B,D) 
cells were cultured on PAN and PJ fibres and exposed to inhibitors for 72 hours as indicated. Cells were seeded 
at a density of 5 × 104 cells/well for both TCP and fibre. The effect of inhibitors was compared between plate vs 
fibres and control vs treatment, using MTT reduction (A,B) and CellTiter-Glo® 3D (C,D) assays. Results are 
expressed at the mean absorbance ± SEM for MTT (n = 6) and mean luminescence ± SEM (n = 3) for CellTiter-
Glo 3D®. *P < 0.05 against plate vs fibres and control vs treatment for plate and fibres was determined by Two-
Way ANOVA with Sidak’s multiple comparisons tests.
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may be due to the increased surface area of cell membranes which is able to interact with the inhibitors on fibres 
compared to cells cultured on a TCP.
Neuronal and glial cell ratios differ in human brain regions51. Several studies have also shown that astrocytes 
support neurons and influence synaptic transmission, plasticity and neuronal protection52. To understand the 
ability of astrocytes to support neuronal cell survival against PD mimetics we designed a co-culture model using 
two separate nanofibre scaffolds. SH-SY5Y cells were cultured in PAN fibres, and U-87MG cells were cultured on 
PJ fibres. Both cell lines were cultured for 48 hours and induced to differentiate using the B27 supplement for five 
days followed by exposure to low concentrations of inhibitors. The viability of both cell types on plate and fibres 
was examined individually using CellTiter-Glo® 3D. The results indicated that neuronal cells exhibit improved 
survival rates when cultured with astrocytes (Fig. 7A,B). Neuronal cells showed prolonged survival against the 
inhibitors for nine days with a gradual loss of viability only seen from the 11th day. This was repeated in astrocyte 
cell populations. The chronic co-culture model has shown how two different types of cells can be co-cultured on 
different surfaces which can be used to recreate a suitable chronic cell culture model of PD. When co-cultured on 
nanofibres, neuronal cells had a lower rate of cell death in response to inhibitors. Studies have shown astrocytes 
can provide the neurotrophic factor like glial cell line-derived neurotrophic factor (GDNF) or brain-derived neu-
rotrophic factor (BDNF)53,54 and the nanofibres may provide a robust structural support that helps to prolong cell 
survival. Several studies have also shown that glial cell line-derived neurotrophic factors can support neuronal 
Figure 7. Effect of inhibitors on SH-SY5Y and U-87MG cells in a co-culture model. Neuronal and 
astrocyte viability was measured after 5 days differentiation in co-culture followed by exposure to inhibitors. 
Differentiated SH-SY5Y (A) and U-87MG (B) separated from the co-culture every 72 hours and measured for 
20 days. Neuronal (C) and astrocyte (D) cultured under same conditions as individual cultures for 72 hours. 
Cells were seeded at a density of 5 × 104 cells/well for both TCP and fibre. In Figure A no significant difference 
in the data was observed for Control vs. MG132 0.1 µM on day2, and Control vs. BSO 2 mM on day 2 and 
5. In Figure B no significant difference in the data was observed for Control vs Rotenone (0.5 µM) on day 2 
and Control vs BSO 2 mM on day 5. All other control vs treatments express a significant difference with a P 
value < 0.05. Results are expressed in mean luminescence value ± SEM (n = 3). Significant differences between 
control vs treatment for each measurement were determined by Two-Way ANOVA with Sidak’s multiple 
comparisons tests (*P < 0.05).
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cell line growth and are very useful to study neurodegenerative diseases like PD55,56. When differentiating neu-
ronal and glial cells were exposed to PD mimetics individually, they exhibited the same response as the undif-
ferentiated cell toxicity test as shown in Section 2.7 (Fig. 7C,D). Both differentiated neurons and astrocytes were 
sensitive to the inhibitors, but the rate of cell death was lower compared to TCP (Fig. 7A,B). It was interesting to 
note that, in contrast to the effects observed on mitotic monocultures, neuronal and glial cells differentiated sep-
arately on fibres were less sensitive to PD mimetics than cells grown on TCP. Further work will help to determine 
whether this reflects differences in the metabolic demand of neural progenitors compared to differentiated cells.
The nanofibre based co-culture model described in the current work represents a long-term 3D differen-
tiated culture model that responds to PD mimetics that have the potential to be used to investigate potential 
neuroprotective agents from both a neuronal and glial perspective. A major benefit of this model compared to 
2D co-culture models of PD, is that neuronal and glial cell types can be co-cultured during exposure then be 
much more easily separated for analysis at a molecular or cellular level to detect cell type- specific changes. The 
enhanced neuroprotective effect against inhibitor treatment observed in scaffold co-cultures, compared to both 
3D and 2D monocultures, also suggests that our 3D model enhances the natural ability of neural cells to afford 
protection to neighbouring cells, providing a strong foundation for longer term chronic exposure studies in vitro.
Using 3D nanofibres scaffolds populated with differentiated neural cells to investigate PD could lead to a 
breakthrough in understanding the importance of simulating the natural habitat of cells, using nanofibres to 
support the survival of different cell types. Taken further, multiple treatments could be investigated and scaled up 
manufacture of suspended nanofibres scaffolds in well plates would improve high content screening models used 
in drug discovery and to identify possible biomarkers linked to the loss of neuronal cells in Parkinson’s disease.
Methods
Electrospinning. PAN, Mw 150,000 (Sigma Aldrich,  UK) was dissolved in 20 ml N,N-
dimethylformamide(DMF) (Fisher Scientific, UK) to form 10 wt% PAN/DMF solution and 5 wt% Jeffamine® 
ED-2003 (Huntsman, Holland BV) in 10 wt% PAN/DMF for PJ solution and heated overnight, 50 °C, with con-
stant stirring. Extensional viscosity was measured using HAAKE-CaBER™ 1 Capillary Breakup Extensional 
Rheometer (Thermo Scientific, UK). A 10 ml syringe was filled and connected to a 21 gauge blunt-end needle 
using 1/32” bore Polytetrafluoroethylene (PTFE) tubing. Polyester sheets 600 × 300 × 0.075 mm were laser cut 
to create 23 by 11 array of 10 mm diameter apertures. One sheet was wrapped around an electrically earthed col-
lector drum. The needle to collector distance was set to 300 mm. A controlled environment of 20 °C and 65%RH 
was maintained throughout the spinning process. A syringe pump (New Era pump system, NY, USA) supplied 
2.5 ml of solution at 1 ml/h to the electrospinning needle which was set at 20 kV for PAN and 16 kV for PJ, to form 
random fibres membranes. These were secured by aligning a second laser cut sheet to the coated sheet and joined 
using ultrasonic spot welding. Laser cutting segmented the array to form individual suspended nanofibres inserts 
compatible with 12 well plates.
Characterisation of nanofibres. Both the integrity and morphology of electrospun nanofibres were 
analysed by sputter coating a gold conductive thin film using an Edwards S150B system, then imaging using a 
Phenom ProX scanning electron microscope (SEM). Diameter and pore size distributions were analysed using 
FiberMetric software. Overlapping fibres and out of focus fibres were manually deselected from the measured 
data. The thickness of the nanoscaffolds were measured using OCT and ImageJ. Contact angles were measured 
from high-speed video frames of 10µl-deionised water dropped on the centre of the scaffolds and the interaction 
of the water droplet recorded for 10 seconds. A water contact angle less than 90 degrees is a hydrophilic surface, 
greater than 90 degrees, a hydrophobic surface57.
Cell culture. Nanofibre inserts were sterilised by soaking in 70% (v/v) ethanol/dH2O for 30 minutes, washed 
twice with sterile phosphate buffered saline (PBS), and equilibrated with cell culture medium before transferring 
to well plates. Human SH-SY5Y neuroblastoma and human U-87MG glioblastoma cells (American Type Culture 
Collection, Manassas, VA) were grown at 37 °C in 5%(v/v) CO2. SH-SY5Y cells were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM)- F12 (Lonza, UK) medium supplemented with 10%(v/v) heat inactivated 
foetal bovine serum (FBS), 2mM L-glutamine (Lonza, UK), penicillin (100 units/ml), streptomycin (100 µg/ml) 
(Lonza, UK), 0.1 mM non-essential amino acids (Lonza, UK). U-87MG cells in Eagle’s minimal essential medium 
(EMEM) with 1 mM sodium pyruvate (Lonza, UK), and supplemented as for DMEM. On reaching 80% conflu-
ency, cells were trypsinised and seeded onto fibre membranes at a density of 5 × 104 cells per insert in a 12 well 
plate.
Cell attachment and proliferation assays. To evaluate the level of attachment and proliferation, cells 
were cultured for 48 hours on both PAN and PJ fibres and then fixed and stained with Coomassie Brilliant Blue 
dye (Sigma-Aldrich, UK) to visualise cell attachment. Both SH-SY5Y and U-87MG were cultured on PAN, PJ 
and TCP seeded at a density of 5 × 104 cell/well. Proliferation and survival of cells on each fibre type and on TCP 
were measured for 11 days with medium changes every 48 hours. Each sample was tested for metabolic activity 
(indicative of proliferation and/or viability) using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) (Sigma Aldrich, UK) reduction assay58,59 every 48 hour period for 11 days. The metabolic activity 
measurement obtained was analysed by comparing it with the data measured 24 hours after cell seeding (day 1 
control|). Cell growth on PAN and PJ fibres were also compared to that of cells cultured on TCP.
Cell differentiation. Experiments were performed on both fibre types in 12 well plates and on poly-L-lysine 
coated coverslips (Bio Coat Inc., USA). SH-SY5Y and U-87MG cells were induced to differentiate by cultur-
ing at 5 × 104 cells/well under normal conditions. Following recovery, both cell types were grown in serum-free 
medium. For SH-SY5Y cells, medium was supplemented with retinoic acid (RA; 1 µM) and B27 supplement (1% 
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(v/v), whereas U-87MG cells were grown in serum-free medium supplemented with dibutyryl cyclic adenosine 
monophosphate (dbcAMP; 0.3 mM) and B27 Supplement (1% v/v). Cells were cultured at 37 °C in 5% (v/v) CO2 
for five days. During differentiation, medium was changed every 48 hours.
Cell imaging. Scanning electron microscopy. After the completion of experimental incubations, cells were 
fixed in 90% (v/v) methanol in Tris buffered saline (TBS: 50 mM Tris-Cl, 150 mM NaCl, pH 7.6) at −20 °C for 
30 minutes. After fixation, cells were dehydrated by sequential incubation in ethanol (v/v) at 30%, 50%, 70%, 
80%, 90% and 100% for 10 min with gentle agitation60,61. After the final dehydration step, samples were air-dried 
for 15 minutes prior to mounting on SEM stubs and sputter coated with a 10 nm thick gold layer. Samples were 
imaged with an SEM at 10 kV.
Immunofluorescence. Following 5 days of cell differentiation, the medium was removed and cells were fixed in 
90% (v/v) methanol in TBS at −20 °C for 30 minutes62. SH-SY5Y and U-87MG cells were stained for βIII tubulin 
and glial fibrillary acidic protein (GFAP), respectively. Cells were permeabilised with 1% (v/v) Triton X-100 in 
TBS. Primary mouse monoclonal anti-βIII tubulin (1:2000; Sigma-Aldrich) and rabbit polyclonal anti-GFAP 
(1:500; New England Biolabs, UK) antibodies were diluted in 3% (w/v) bovine serum albumin in TBS and 
incubated at 4 °C overnight. Because PAN and PJ nanofibres autofluoresce emitting green light, Alexa Fluor™ 
568 goat anti-mouse Ig for anti-βIII tubulin and Alexa Fluor™ 568 chicken anti-rabbit Ig for GFAP (both from 
Cell Signalling, UK) were used at 1:200 dilutions. Cells were mounted on glass slides and counterstained with 
4′,6-diamidino-2-phenylindole dihydrochloride (DAPI; Vector Laboratories Ltd., UK).
Western blot analysis. Cells were cultured and differentiated on each fibre type, then washed twice with 
PBS, transferred into a tube and solubilised with RIPA buffer (Sigma-Aldrich) supplemented with 0.2% (v/v) 
protease inhibitor cocktail (Sigma Aldrich). Samples were vortex-mixed to break the fibres and cultures apart and 
create a protein extract. For comparison, cell pellets were also obtained by scraping cell monolayers on TCP in 
12 well plates, followed by centrifuging at 300 g for 5 minutes. Pellets were resuspended in RIPA buffer with 0.2% 
(v/v) protease inhibitor cocktail. The protein concentration of each sample was determined using the Mini Lowry 
protein estimation assay. A total of 20 µg of cell lysate protein was separated by sodium dodecyl sulphate poly-
acrylamide gel electrophoresis (SDS-PAGE) using a 10% (w/v) polyacrylamide resolving gel. Proteins were trans-
ferred electrophoretically onto a nitrocellulose membrane filter and blocked. Lysates from SH-SY5Y cells were 
probed with mouse monoclonal anti-phosphorylated neurofilament heavy chain (NF-H) SMI 34 diluted 1:100 
(Bio Legend, UK), mouse anti-βIII –tubulin [2G10] diluted 1:1000 (Abcam, UK), and mouse anti-synaptophysin 
diluted 1:10000 (Abcam, UK). U-87MG cell lysates were probed with rabbit anti-GFAP diluted 1:500 (GeneTex, 
UK). Samples were also probed with mouse anti-β actin 1:1000 GT5512 (GeneTex, UK) as a loading control 
for SMI 34 and rabbit anti-vinculin 1:5000 (Abcam, UK ab73412) as loading control for βIII tubulin, synap-
tophysin and GFAP. The membranes were probed with horseradish peroxidase-conjugated goat anti-mouse or 
goat anti-rabbit immunoglobulin, at 1:500. Antibody binding was detected by enhanced chemiluminescence and 
images were obtained using a Fujifilm LAS-4000 scanner) and band intensities quantified using Advanced Image 
Data Analyser Software (Raytek, Sheffield, UK)
Cell treatments with different PD mimetics. Biochemical abnormalities found in PD can be induced 
with inhibitors that impair the functionality of the cells63. Mitotic SH-SY5Y and U-87MG cells were incubated at 
a density of 5 × 104 cells/well on fibres and on plates. After 24 hours, the scaffolds were transferred to new plates. 
Both types were incubated for 24 hours at 37 °C with 5% (v/v) CO2 supply. After 48 hours, the medium was replaced 
with fresh medium containing PD mimetics at different concentrations. The inhibitors used were rotenone (0.5 µM 
and 2.5 µM) and 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine (MPTP) (10 µM and 100 µM) to induce complex 
Figure 8. Schematic of co-culture model. (A) Neuronal cells cultured on PAN fibres. (B) Hollow acrylic spacer 
(C) Astrocytes on PJ fibres.
1 2Scientific RepoRtS |         (2020) 10:2767  | https://doi.org/10.1038/s41598-020-59310-x
www.nature.com/scientificreportswww.nature.com/scientificreports/
1 inhibition64,65, MG132 (0.1 µM and 0.5 µM) inducing proteasome inhibition66 and BSO (2.0 mM),a glutamyl-
cysteine synthetase inhibitor, to reduce glutathione levels67. These were incubated under normal conditions for 
72 hours and were tested for viability using the MTT and CellTiter-Glo® 3D assays (Promega UK).
Co-culture model to test PD mimetics. The effects of inhibitors on SH-SY5Y cells co-cultured in the 
presence of U-87 MG was investigated. SH-SY5Y cells were cultured on PAN and U-87MG on PJ scaffolds. 
Initially, both cell lines were seeded individually at a density of 5 × 104 cells/ml, cultured for 48 hours and induced 
to differentiate with B27 supplement for five days. After five days, fibres scaffolds were arranged as shown in Fig. 8 
and 0.5 µM rotenone, 0.1 µM MG132 and 2 mM BSO were added to the co-culture, which was exposed for 20 
days to recreate the longer term, chronic model. Every 72 hours the fibres were transferred from each well into a 
fresh culture dish to measure viability and new medium with inhibitors was replaced for the remaining wells. Cell 
viability was examined for each fibre type using CellTiter-Glo® 3D. Simultaneously, under the same condition 
monoculture of both differentiated SH-SY5Y and U-87MG on PAN and PJ respectively were exposed to the same 
concentrations of inhibitors and cell viability was determined.
Statistical analysis. Unless otherwise specified in figure legends, values obtained for proliferation and via-
bility assessments were converted to a percentage of the corresponding control. The data obtained were normally 
distributed (as ascertained by the Kolmogorov-Smirnov Test for Normality). Statistical analysis was performed 
using the Two-Way ANOVA with Sidak’s multiple comparisons tests. The two-way ANOVA compares the mean 
differences between groups that have been split into two independent variables (Plate and Fibre) and the Sidak 
multiple comparisons was applied to compare each time point against the two variables. All data presented as 
mean ± the standard deviation (SD). Statistical analysis was performed on all datasets, and all analysis was con-
ducted using the Graph Pad Prism for Windows Version 7.02. P-values that were considered statistically signifi-
cant and were indicated within figures as *p < 0.05, **p < 0.01 or ***p < 0.001.
Data availability
The raw/processed data required to reproduce these findings are available upon request.
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